Pacific Biosciences of California, Inc. (PACB) financial statements (2022 and earlier)

Company profile

Business Address 1305 O'BRIEN DRIVE
MENLO PARK, CA 94025
State of Incorp. DE
Fiscal Year End December 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1,04431949102637282
Cash and cash equivalents461823019171734
Short-term investments5842371984465549
Other undisclosed cash, cash equivalents, and short-term investments    0  
Restricted cash and investments12     
Receivables2417159131615
Inventory, net of allowances, customer advances and progress billings25141318231611
Inventory25141318231611
Prepaid expense    121
Other current assets    101
Other undisclosed current assets7433(0)2 
Total current assets:1,10135681132102109111
Noncurrent Assets
Operating lease, right-of-use asset473033
Property, plant and equipment3325303438159
Intangible assets, net (including goodwill)821      
Goodwill410      
Intangible assets, net (excluding goodwill)411      
Restricted cash and investments5445555
Other noncurrent assets10000108
Total noncurrent assets:906586739422921
TOTAL ASSETS:2,007414148170144138131
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities47212220222528
Accounts payable11487985
Accrued liabilities36171313131716
Employee-related liabilities      8
Deferred revenue1198
Debt2 20    
Other liabilities6501120
Other undisclosed current liabilities64 76710
Total current liabilities:72394927293438
Noncurrent Liabilities
Long-term debt and lease obligation52384215141615
Long-term debt, excluding current maturities2  15141615
Operating lease, liability503842
Liabilities, other than long-term debt19822141522
Deferred revenue and credits14  
Deferred revenue2522
Deferred rent credit   14
Other liabilities31   21
Business combination, contingent consideration, liability170      
Derivative instruments and hedges, liabilities   0001
Other undisclosed noncurrent liabilities894  1112
Total noncurrent liabilities:1,144404429291919
Total liabilities:1,216789356585358
Stockholders' equity
Stockholders' equity attributable to parent79133555114868574
Common stock0000000
Additional paid in capital2,0101,3721,1211,096966872787
Accumulated other comprehensive income (loss)(1)00(0)(0)0(0)
Accumulated deficit(1,218)(1,037)(1,066)(982)(880)(788)(713)
Total stockholders' equity:79133555114868574
TOTAL LIABILITIES AND EQUITY:2,007414148170144138131

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues131799179939193
Revenue, net937948
Cost of revenue(72)(46)(56)(54)(59)(47)(39)
Cost of goods and services sold(0)(46)(56)(54)(43)(35)(31)
Other cost of operating revenue    (16)(12)(9)
Gross profit:59333525354453
Operating expenses(269)(137)(135)(126)(124)(115)(83)
Operating loss:(210)(104)(101)(101)(90)(71)(29)
Nonoperating income (expense)(52)36191100
Gain (loss) on contract termination(52)3418    
Other nonoperating income0211100
Interest and debt expense(13)(0)(3)(2)(3)(3)(3)
Loss from continuing operations before income taxes:(275)(69)(84)(103)(92)(74)(32)
Income tax benefit94      
Net loss:(181)(69)(84)(103)(92)(74)(32)
Other undisclosed net income attributable to parent 98     
Net income (loss) available to common stockholders, diluted:(181)29(84)(103)(92)(74)(32)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(181)(69)(84)(103)(92)(74)(32)
Comprehensive loss:(181)(69)(84)(103)(92)(74)(32)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1)980(0)(0)0(0)
Comprehensive income (loss), net of tax, attributable to parent:(182)29(84)(103)(92)(74)(32)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: